A recent article in JAMA Dermatology reviewed key aspects of dermatologic healthcare delivery for persons experiencing homelessness (PEH). For a variety of reasons , rates of homelessness are increasing among both rural and urban populations in the US. According to the article, PEH “experience high rates of ectoparasitic, fungal, and sexually transmitted infections; chronic wounds; …
Psoriasis is a common chronic autoimmune skin condition. Patients who have psoriasis have increased rates of depression and cardiovascular disease. Additionally, up to one third of patients who have psoriasis will suffer from psoriatic arthritis. A recent study in JAMA Dermatology investigated the association between cancer and psoriasis. It is hypothesized the chronic inflammation that …
Faculty: Lindsay Ackerman, MD Dr. Lindsay Ackerman presented a discussion of dermatology controversies from her work in the Scientific Advisory Committee (SAC) with US Dermatology Partners. She began with a review of superficial radiation (SRT) in the treatment of non-melanoma skin cancers (NMSC). In most cases, brachytherapy is the way in which SRT is delivered. …
Psoriasis is a chronic immune-mediated inflammatory skin disease. Patient with psoriasis typically present with erythematous scaling patches and plaques on the elbows, knees, scalp and buttocks. Up to 30 percent of patients who have psoriasis will develop psoriatic arthritis. It has been found that patients who have psoriasis are at an increased risk of comorbidities …
Featuring Guest Faculty, Jeffrey Johnson, PA-C For Friday afternoon’s product theater, Jeffrey Johnson, PA-C , discussed psoriasis and treatment with Tremfya. Mr. Johnson reminded the audience psoriasis is not just an inflammatory skin disease but a global inflammatory disease which can affect all organ systems. For example, patients with moderate to severe psoriasis are 54% …
Featuring Larry Green, MD Dr. Larry Green presented a new medication for the treatment of psoriasis that will soon be released in the US. Duobrii is a once daily topical emulsion lotion that is FDA approved for the treatment of psoriasis. Dr. Green reports when psoriasis patients are surveyed, 100% have used topical treatments, while …